A Specific Inhibitor of TGF-β Receptor Kinase, SB-431542, as a Potent Antitumor Agent for Human Cancers

TGF-β SIGNAL TRANSDUCTION

Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571 · see citing works

Lessons from hereditary colorectal cancer

Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919 · see citing works

TGF-β signalling from cell membrane to nucleus through SMAD proteins

Heldin, C., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,697 · see citing works

TGF-β Signaling in Tumor Suppression and Cancer Progression

Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275 · see citing works

Transcriptional control by the TGF‐β/Smad signaling system

Massagué, J., & Wotton, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,969 · see citing works

SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7

Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,636 · see citing works

Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer

Siegel, P. M., & Massagué, J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1208 · Cited by 1,600 · see citing works

Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.

Bhowmick, N., Ghiassi, M., Bakin, A. V., Aakre, M., Lundquist, C., Engel, M., Arteaga, C., & Moses, H. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,087 · see citing works

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

Ashcroft, G. S., Yang, X., Glick, A. B., Weinstein, M., Letterio, J. J., Mizel, D. E., Anzano, M., Greenwell-Wild, T., Wahl, S. M., Deng, C., et al. (1999) · Nature Cell Biology · doi:10.1038/12971 · Cited by 911 · see citing works

TGF-β signaling: positive and negative effects on tumorigenesis

Wakefield, L. M. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00259-3 · Cited by 827 · see citing works

Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.

Postlethwaite, A. E., Keski-Oja, J., Moses, H. L., & Kang, A. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.1.251 · Cited by 777 · see citing works

Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542

Laping, N. J., Grygielko, E. T., Mathur, A., Butter, S., Bomberger, J. M., Tweed, C. W., Martin, W., Fornwald, J. A., Lehr, R. V., Harling, J. D., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.58 · Cited by 638 · see citing works

TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis

Oft, M., Heider, K., & Beug, H. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00533-7 · Cited by 624 · see citing works

Smads as transcriptional co-modulators

Attisano, L., & Wrana, J. L. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00081-2 · Cited by 523 · see citing works

Role of Transforming Growth Factor-beta Signaling in Cancer

de Caestecker, M. P. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.17.1388 · Cited by 521 · see citing works

Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases

Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S. T., Gotwals, P. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15234 · Cited by 485 · see citing works

p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration

Bakin, A. V., Rinehart, C., Tomlinson, A. K., & Arteaga, C. L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.15.3193 · Cited by 430 · see citing works

Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases

Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S. T., Gotwals, P. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215234 · Cited by 415 · see citing works

Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

Yang, Y.-A., Dukhanina, O. I., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15333 · Cited by 404 · see citing works

Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects

Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404 · see citing works

Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.

Ellenrieder, V., Hendler, S. F., Boeck, W., Seufferlein, T., Menke, A., Ruhland, C., Adler, G., & Gress, T. M. (2001) · PubMed · Cited by 361 · see citing works

Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)

Callahan, J. F., Burgess, J. L., Fornwald, J. A., Gaster, L. M., Harling, J. D., Harrington, F. P., Heer, J. P., Kwon, C., Lehr, R. V., Mathur, A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010493y · Cited by 309 · see citing works

Targeting the TGFβ signaling network in human neoplasia

Dumont, N., & Arteaga, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00135-1 · Cited by 243 · see citing works

Transforming Growth Factor-β1 Enhances Ha-ras-induced Expression of Cyclooxygenase-2 in Intestinal Epithelial Cells via Stabilization of mRNA

Sheng, H., Shao, J., Dixon, D. A., Williams, C. S., Prescott, S. M., DuBois, R. N., & Beauchamp, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6628 · Cited by 196 · see citing works

SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.

Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X.-F., & Rich, J. N. (2004) · PubMed · Cited by 192 · see citing works

SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility

Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X., & Rich, J. N. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.737.3.6 · Cited by 177 · see citing works

TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell–derived endothelial cells

Watabe, T., Nishihara, A., Mishima, K., Yamashita, J. K., Shimizu, K., Miyazawa, K., Nishikawa, S., & Miyazono, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305147 · Cited by 176 · see citing works

SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.

Matsuyama, S., Iwadate, M., Kondo, M., Saitoh, M., Hanyu, A., Shimizu, K., Aburatani, H., Mishima, H. K., Imamura, T., Miyazono, K., et al. (2003) · PubMed · Cited by 142 · see citing works

Chemoinformatics – predicting the physicochemical properties of 'drug-like' molecules

Blake, J. F. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00062-2 · Cited by 137 · see citing works

Growth factors and transformation.

Roberts, A. B., & Sporn, M. B. (1986) · PubMed · Cited by 128 · see citing works

Diet diversity and gastric cancer

Vecchia, C. L., Muñoz, S. E., Braga, C., Fernández, E., & Decarli, A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970717)72:2 · Cited by 107 · see citing works

Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.

Osada, H., Tatematsu, Y., Masuda, A., Saito, T., Sugiyama, M., Yanagisawa, K., & Takahashi, T. (2001) · PubMed · Cited by 83 · see citing works

Signal Transduction of the TGF- Superfamily by Smad Proteins

Kawabata, M., & Miyazono, K. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022273 · Cited by 65 · see citing works

Crossing Smads

Wrana, J. L. (2000) · Science s STKE · doi:10.1126/stke.2000.23.re1 · Cited by 52 · see citing works

TGF-β signaling in health, disease and therapeutics

Deng, Z., Fan, T. T., Chu, X., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,270 · see citing works

Tissue invasion and metastasis: Molecular, biological and clinical perspectives

Jiang, W. G., Sanders, A. J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M. E., Thompson, S. K., Zollo, M., Spano, D., Dhawan, P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.008 · Cited by 514 · see citing works

Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation

Spencer, M., Yao-Borengasser, A., Unal, R., Rasouli, N., Gurley, C. M., Zhu, B., Peterson, C. A., & Kern, P. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00329.2010 · Cited by 439 · see citing works

Dysregulation of growth factor signaling in human hepatocellular carcinoma

Breuhahn, K., Longerich, T., & Schirmacher, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209556 · Cited by 392 · see citing works

Epithelial–mesenchymal transition and tumour invasion

Guarino, M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.07.011 · Cited by 369 · see citing works

Targeting EMT in cancer: opportunities for pharmacological intervention

Davis, F. M., Stewart, T. A., Thompson, E. W., & Monteith, G. R. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.06.006 · Cited by 361 · see citing works

EMT Factors and Metabolic Pathways in Cancer

Georgakopoulos‐Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V. E., & Zaravinos, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00499 · Cited by 348 · see citing works

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

Melisi, D., Ishiyama, S., Sclabas, G. M., Fleming, J. B., Xia, Q., Tortora, G., Abbruzzese, J. L., & Chiao, P. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0337 · Cited by 324 · see citing works

Drug resistance in cancer: mechanisms and tackling strategies

Haider, T., Pandey, V., Banjare, N., Gupta, P. N., & Soni, V. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00138-7 · Cited by 312 · see citing works

Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology

Rout-Pitt, N., Farrow, N., Parsons, D., & Donnelley, M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0834-8 · Cited by 275 · see citing works

Dynamic actin remodeling during epithelial–mesenchymal transition depends on increased moesin expression

Haynes, J., Srivastava, J., Madson, N., Wittmann, T., & Barber, D. L. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0119 · Cited by 241 · see citing works

Reduced Expression of Connective Tissue Growth Factor (CTGF/CCN2) Mediates Collagen Loss in Chronologically Aged Human Skin

Quan, T., Shao, Y., He, T., Voorhees, J. J., & Fisher, G. J. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.224 · Cited by 239 · see citing works

Antimetastatic Role of Smad4 Signaling in Colorectal Cancer

Zhang, B., Halder, S. K., Kashikar, N., Cho, Y., Datta, A., Gorden, D. L., & Datta, P. K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.11.004 · Cited by 221 · see citing works

Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer

Jordan, N. V., Johnson, G. L., & Abell, A. N. (2011) · Cell Cycle · doi:10.4161/cc.10.17.17188 · Cited by 220 · see citing works

Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor

Patsialou, A., Wyckoff, J. B., Wang, Y., Goswami, S., Stanley, E. R., & Condeelis, J. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1868 · Cited by 207 · see citing works

Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor Microenvironment

Achyut, B. R., & Yang, H. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.048 · Cited by 200 · see citing works

Activin signaling as an emerging target for therapeutic interventions

Tsuchida, K., Nakatani, M., Hitachi, K., Uezumi, A., Sunada, Y., Ageta, H., & Inokuchi, K. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-15 · Cited by 195 · see citing works

Molecular and cellular mechanisms of chemoresistance in pancreatic cancer

Adamska, A., Elaskalani, O., Emmanouilidi, A., Kim, M. K., Razak, N. B. A., Metharom, P., & Falasca, M. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.11.007 · Cited by 184 · see citing works

Canonical TGF-β Signaling Pathway Represses Human NK Cell Metabolism

Zaiatz-Bittencourt, V., Finlay, D. K., & Gardiner, C. M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701461 · Cited by 177 · see citing works

Posttranscriptional Control of the Stem Cell and Neurogenic Programs by the Nonsense-Mediated RNA Decay Pathway

Lou, C. H., Shao, A., Shum, E. Y., Espinoza, J. L., Huang, L., Karam, R., & Wilkinson, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.028 · Cited by 172 · see citing works

Signal Transduction Pathway through Activin Receptors as a Therapeutic Target of Musculoskeletal Diseases and Cancer

Tsuchida, K., Nakatani, M., Uezumi, A., Murakami, T., & Cui, X. (2008) · Endocrine Journal · doi:10.1507/endocrj.kr-110 · Cited by 163 · see citing works

Transforming growth factor‐β in cutaneous melanoma

Javelaud, D., Alexaki, V. I., & Mauviel, A. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00450.x · Cited by 150 · see citing works

Antibody-Mediated Blockade of Integrin αvβ6 Inhibits Tumor Progression <i>In vivo</i> by a Transforming Growth Factor-β–Regulated Mechanism

Koopman Van Aarsen, L. A., Leone, D. R., Ho, S., Dolinski, B. M., McCoon, P. E., LePage, D. J., Kelly, R., Heaney, G., Rayhorn, P., Reid, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2307 · Cited by 146 · see citing works

Exploring anti-TGF-β therapies in cancer and fibrosis

Hawinkels, L. J. A. C., & ten Dijke, P. (2011) · Growth Factors · doi:10.3109/08977194.2011.595411 · Cited by 145 · see citing works

TGF-β signaling in liver and gastrointestinal cancers

Katz, L. H., Likhter, M., Jogunoori, W. S., Belkin, M. D., Ohshiro, K., & Mishra, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.033 · Cited by 145 · see citing works

Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients

Patsialou, A., Wang, Y., Lin, J., Whitney, K. D., Goswami, S., Kenny, P. A., & Condeelis, J. S. (2012) · Breast Cancer Research · doi:10.1186/bcr3344 · Cited by 144 · see citing works

The Role of Actin Dynamics and Actin-Binding Proteins Expression in Epithelial-to-Mesenchymal Transition and Its Association with Cancer Progression and Evaluation of Possible Therapeutic Targets

Izdebska, M., Zielińska, W., Grzanka, D., & Gagat, M. (2018) · BioMed Research International · doi:10.1155/2018/4578373 · Cited by 142 · see citing works

Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer

Zhao, J., Schlößer, H., Wang, Z., Qin, J., Li, J., Popp, F., Popp, M. C., Alakus, H., Chon, S., Hansen, H. P., et al. (2019) · Cancers · doi:10.3390/cancers11060874 · Cited by 142 · see citing works

Targeting transforming growth factor-β signaling in liver metastasis of colon cancer

Zhang, B., Halder, S. K., Zhang, S., & Datta, P. K. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.035 · Cited by 134 · see citing works

Elevated Cysteine-Rich 61 Mediates Aberrant Collagen Homeostasis in Chronologically Aged and Photoaged Human Skin

Quan, T., He, T., Shao, Y., Lin, L., Kang, S., Voorhees, J. J., & Fisher, G. J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060128 · Cited by 130 · see citing works

Immunity and Immune Suppression in Human Ovarian Cancer

Preston, C. C., Goode, E. L., Hartmann, L. C., Kalli, K. R., & Knutson, K. L. (2011) · Immunotherapy · doi:10.2217/imt.11.20 · Cited by 130 · see citing works

Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness

Gaspar, N. J., Li, L., Kapoun, A. M., Medicherla, S., Reddy, M., Li, G., O’Young, G., Quon, D. H., Henson, M., Damm, D. L., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029025 · Cited by 120 · see citing works

Pharmacological Inhibition of Platelet-Tumor Cell Cross-Talk Prevents Platelet-Induced Overexpression of Cyclooxygenase-2 in HT29 Human Colon Carcinoma Cells

Dovizio, M., Maier, T. J., Alberti, S., Francesco, L. D., Marcantoni, E., Münch, G., John, C. M., Suess, B., Sgambato, A., Steinhilber, D., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084988 · Cited by 120 · see citing works

CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling

Ying, Z., Tian, H., Li, Y., Lian, R., Li, W., Wu, S., Zhang, H., Wu, J., Liu, L., Song, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90439 · Cited by 120 · see citing works

Transforming growth factor-beta signaling and tumor angiogenesis

Pardali, E. (2009) · Frontiers in bioscience · doi:10.2741/3573 · Cited by 117 · see citing works

TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives

Mancarella, S., Cigliano, A., Chieti, A., Giannelli, G., & Dituri, F. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1676121 · Cited by 114 · see citing works

Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway

Zhang, B., Zhang, B., Chen, X., Bae, S., Singh, K. P., Washington, M. K., & Datta, P. K. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.789 · Cited by 113 · see citing works

Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model

Drabsch, Y., He, S., Zhang, L., Snaar-Jagalska, E. B., & ten Dijke, P. (2013) · Breast Cancer Research · doi:10.1186/bcr3573 · Cited by 113 · see citing works

Homeoprotein Six1 Increases TGF-β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth

Micalizzi, D. S., Wang, C.-A., Farabaugh, S. M., Schiemann, W. P., & Ford, H. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1354 · Cited by 113 · see citing works

Naringenin Decreases Invasiveness and Metastasis by Inhibiting TGF-β-Induced Epithelial to Mesenchymal Transition in Pancreatic Cancer Cells

Lou, C., Zhang, F., Yang, M., Zhao, J., Zeng, W., Fang, X., Zhang, Y., Zhang, C., & Liang, W. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050956 · Cited by 109 · see citing works

Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway

Das, S., Becker, B. N., Hoffmann, F. M., & Mertz, J. E. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-94 · Cited by 109 · see citing works

NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype

Oh, A., Pardo, M. R., Rodriguez, A., Yu, C., Nguyen, L., Liang, O. D., Chorzalska, A. D., & Dubielecka, P. M. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01207-z · Cited by 110 · see citing works

Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy

Iiizumi, M., Liu, W., Pai, S. K., Furuta, E., & Watabe, K. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.07.002 · Cited by 105 · see citing works

Inhibition of TGFβ signaling in cancer therapy

Arteaga, C. L. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.009 · Cited by 105 · see citing works

Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β

Sandbo, N. K., Lau, A., Kach, J., Ngam, C. R., Yau, D. M., & Dulin, N. O. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00166.2011 · Cited by 104 · see citing works

Suppression of transforming growth factor β signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations

Wildi, S., Kleeff, J. H., Mayerle, J. V., Zimmermann, A., Böttinger, E. P., Wakefield, L. M., Büchler, M. W., Frieß, H., & Korc, M. (2006) · Gut · doi:10.1136/gut.2006.105833 · Cited by 102 · see citing works

Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells

Bedel, R., Thiery-Vuillemin, A., Grandclément, C., Balland, J., Rémy-Martin, J.-P., Kantelip, B. M., Pallandre, J., Pivot, X. B., Ferrand, C., Tiberghien, P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-09-4540 · Cited by 99 · see citing works

EMT and Stemness—Key Players in Pancreatic Cancer Stem Cells

Rodríguez-Aznar, E., Wiesmüller, L., Sainz, B., & Hermann, P. (2019) · Cancers · doi:10.3390/cancers11081136 · Cited by 93 · see citing works

Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands

SenGupta, S., Hein, L. E., Xu, Y., Zhang, J., Konwerski, J. R., Li, Y., Johnson, C. N., Cai, D., Smith, J. L., & Parent, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.659996 · Cited by 93 · see citing works

TGF-β signaling engages an ATM-CHK2-p53–independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells

Cipriano, R., Kan, C. E., Graham, J., Danielpour, D., Stampfer, M., & Jackson, M. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015022108 · Cited by 92 · see citing works

Oncogenic Function of a Novel WD-Domain Protein, STRAP, in Human Carcinogenesis

Halder, S. K., Anumanthan, G., Maddula, R., Mann, J. R., Chytil, A. M., Gonzalez, A. L., Washington, M. K., Moses, H. L., Beauchamp, R. D., & Datta, P. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3261 · Cited by 91 · see citing works

TGF-β signaling networks in the tumor microenvironment

Chan, M. K.-K., Chung, J. Y.-F., Tang, P. C.-T., Chan, A. S.-W., Ho, J. Y.-Y., Lin, T. P.-T., Chen, J., Leung, K.-T., To, K.-F., Lan, H.-Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215925 · Cited by 90 · see citing works

Integrating Genomic, Epigenomic, and Transcriptomic Features Reveals Modular Signatures Underlying Poor Prognosis in Ovarian Cancer

Zhang, W., Liu, Y., Sun, N., Wang, D., Boyd-Kirkup, J. D., Dou, X., & Han, J. J. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.010 · Cited by 89 · see citing works

VEGF and inhibitors of TGFβ type-I receptor kinase synergistically promote blood-vessel formation by inducing α5-integrin expression

Liu, Z., Kobayashi, K., van Dinther, M., van Heiningen, S. H., Valdimarsdóttir, G., van Laar, T., Scharpfenecker, M., Löwik, C. W. G. M., Goumans, M., ten Dijke, P., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.048942 · Cited by 89 · see citing works

Cell surface thermal proteome profiling tracks perturbations and drug targets on the plasma membrane

Kalxdorf, M., Günthner, I., Becher, I., Kurzawa, N., Knecht, S., Savitski, M. M., Eberl, H. C., & Bantscheff, M. (2021) · Nature Methods · doi:10.1038/s41592-020-01022-1 · Cited by 88 · see citing works

Smoking Induces Epithelial-to-Mesenchymal Transition in Non–Small Cell Lung Cancer through HDAC-Mediated Downregulation of E-Cadherin

Nagathihalli, N. S., Massion, P. P., Gonzalez, A. L., Wang, L., & Datta, P. K. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0107 · Cited by 86 · see citing works

The Tumor Suppressor Smad4/DPC4 Is Regulated by Phosphorylations that Integrate FGF, Wnt, and TGF-β Signaling

Demagny, H., Araki, T., & Robertis, E. M. D. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.020 · Cited by 85 · see citing works

The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors

Liaghat, M., Ferdousmakan, S., Mortazavi, S. H., Yahyazadeh, S., Irani, A., Banihashemi, S., Asl, F. S. S., Akbari, A., Farzam, F., Aziziyan, F., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01957-4 · Cited by 84 · see citing works

Role of Transforming Growth Factor-β In Cancer Progression

Galliher, A. J., Neil, J. R., & Schiemann, W. P. (2006) · Future Oncology · doi:10.2217/14796694.2.6.743 · Cited by 80 · see citing works

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer

Legras, A., Pécuchet, N., Imbeaud, S., Pallier, K., Didelot, A., Roussel, H., Gibault, L., Fabre, E., Pimpec‐Barthes, F. L., Laurent‐Puig, P., et al. (2017) · Cancers · doi:10.3390/cancers9080101 · Cited by 78 · see citing works

Metallodrugs: an approach against invasion and metastasis in cancer treatment

González-Ballesteros, M. M., Mejía, C., & Ruíz-Azuara, L. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13381 · Cited by 79 · see citing works

Kefir exhibits anti-proliferative and pro-apoptotic effects on colon adenocarcinoma cells with no significant effects on cell migration and invasion

KHOURY, N., EL-HAYEK, S., TARRAS, O., EL-SABBAN, M., EL-SIBAI, M., & RIZK, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2635 · Cited by 77 · see citing works

The TGF-β Signalling Network in Muscle Development, Adaptation and Disease

Chen, J. L., Colgan, T. D., Walton, K. L., Gregorevic, P., & Harrison, C. A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-27511-6_5 · Cited by 76 · see citing works

Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts

Atanasova, V. S., Russell, R. J., Webster, T. G., Cao, Q., Agarwal, P., Lim, Y. Z., Krishnan, S. M., Fuentes, I., Guttmann‐Gruber, C., McGrath, J. A., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.011 · Cited by 75 · see citing works

TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases

Buijs, J. T., Stayrook, K. R., & Guise, T. A. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0075-6 · Cited by 73 · see citing works

The activated transforming growth factor‐beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer

Yamamura, S., Matsumura, N., Mandai, M., Huang, Z., Oura, T., Baba, T., Hamanishi, J., Yamaguchi, K. D., Kang, H., Okamoto, T., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25961 · Cited by 73 · see citing works

Silver nanoparticles/chitosan oligosaccharide/poly(vinyl alcohol) nanofiber promotes wound healing by activating TGFβ1/Smad signaling pathway

Li, C.-W., Wang, Q., Li, J., Hu, M., Shi, S.-J., Li, Z.-W., Wu, G.-L., Cui, H.-H., Li, Y.-Y., Zhang, Q., et al. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s91975 · Cited by 89 · see citing works

Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish

Yan, C., Huo, X., Wang, S., Feng, Y., & Gong, Z. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.024 · Cited by 72 · see citing works

Targeting transforming growth factor-β signaling

Pennison, M. J., & Pasche, B. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f0ad0e · Cited by 71 · see citing works

Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells

Park, N. R., Hoon, J., Jang, J. W., Bae, S. H., Jang, B., Kim, J., Hur, W., Choi, J. Y., & Yoon, S. K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.077 · Cited by 70 · see citing works

Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells

Roudnicky, F., Zhang, J. D., Kim, B. K., Pandya, N. J., Lan, Y., Sach-Peltason, L., Ragelle, H., Strassburger, P., Gruener, S., Lazendic, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911532117 · Cited by 66 · see citing works

High-Dose TGF-β1 Impairs Mesenchymal Stem Cell–Mediated Bone Regeneration via Bmp2 Inhibition

Xu, J., Liu, J., Gan, Y., Dai, K., Zhao, J., Huang, M., Huang, Y., Zhuang, Y., & Zhang, X. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3871 · Cited by 68 · see citing works

Microvesicles in Health and Disease

Inal, J. M., Ansa-Addo, E. A., Stratton, D., Kholia, S., Antwi-Baffour, S. S., Jorfi, S., & Lange, S. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0165-2 · Cited by 68 · see citing works

Tumor-Specific Efficacy of Transforming Growth Factor-βRI Inhibition in Eker Rats

Laping, N. J., Everitt, J. I., Frazier, K. S., Burgert, M. E., Portis, M. J., Cadacio, C., Gold, L. I., & Walker, C. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1811 · Cited by 67 · see citing works

Tendon‐derived extracellular matrix induces mesenchymal stem cell tenogenesis via an integrin/transforming growth factor‐β crosstalk‐mediated mechanism

Wang, D. M., Pun, C. C.-M., Huang, S., Tang, T., Ho, K. K., Rothrauff, B. B., Yung, P. S., Blocki, A. M., Ker, D. F. E., & Tuan, R. S. (2020) · The FASEB Journal · doi:10.1096/fj.201902377rr · Cited by 66 · see citing works

Myeloid-derived Suppressor Cells (MDSCs) in Gliomas and Glioma-Development

Kohanbash, G., & Okada, H. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.689591 · Cited by 65 · see citing works

Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells

Anumanthan, G., Halder, S., Osada, H., Takahashi, T., Massion, P. P., Carbone, D. P., & Datta, P. K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602831 · Cited by 64 · see citing works

Molecular Mechanisms Regulating Epithelial Mesenchymal Transition (EMT) to Promote Cancer Progression

Ghafoor, S., Garcia, E. P., Jay, D. J., & Persad, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094364 · Cited by 68 · see citing works

The role played by endocytosis in albumin-induced secretion of TGF-β1by proximal tubular epithelial cells

Diwakar, R., Pearson, A. L., Colville‐Nash, P., Brunskill, N. J., & Dockrell, M. E. C. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00069.2006 · Cited by 63 · see citing works

Claudin-3 overexpression increases the malignant potential of colorectal cancer cells: roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling

de Souza, W. F., Fortunato-Miranda, N., Robbs, B. K., de Araujo, W. M., de-Freitas-Junior, J. C., Bastos, L. G., Viola, J. P. B., & Morgado-Díaz, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074994 · Cited by 62 · see citing works

Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression

Yu, Y., & Elble, R. C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020026 · Cited by 60 · see citing works

SOX4 can redirect TGF-β-mediated SMAD3-transcriptional output in a context-dependent manner to promote tumorigenesis

Vervoort, S. J., Lourenço, A. R., Vidaković, A. T., Mocholí, E., Sandoval, J. L., Rueda, O. M., Frederiks, C. L., Pals, C. E. G. M., Peeters, J. G. C., Caldas, C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky755 · Cited by 59 · see citing works

TGF-β1/Smad Signaling Pathway Regulates Epithelial-to-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma: In Vitro and Clinical Analyses of Cell Lines and Nomadic Kazakh Patients from Northwest Xinjiang, China

Pang, L., Li, Q., Wei, C., Zou, H., Li, S., Cao, W., He, J., Zhou, Y., Ju, X., Lan, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112300 · Cited by 57 · see citing works

TGFβ1 induces IL‐6 and inhibits IL‐8 release in human bronchial epithelial cells: The role of Smad2/3

Ge, Q., Moir, L. M., Black, J. L., Oliver, B. G. G., & Burgess, J. K. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22295 · Cited by 58 · see citing works

Human Plasma Membrane-Derived Vesicles Halt Proliferation and Induce Differentiation of THP-1 Acute Monocytic Leukemia Cells

Ansa-Addo, E. A., Lange, S., Stratton, D., Antwi-Baffour, S. S., Cestari, I. D. S., Ramirez, M. I., McCrossan, M. V., & Inal, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001656 · Cited by 58 · see citing works

Tumor Initiating Cells and Chemoresistance: Which Is the Best Strategy to Target Colon Cancer Stem Cells?

Paldino, E., Tesori, V., Casalbore, P., Gasbarrini, A., & Puglisi, M. A. (2014) · BioMed Research International · doi:10.1155/2014/859871 · Cited by 57 · see citing works

Human Family with Sequence Similarity 60 Member A (FAM60A) Protein: a New Subunit of the Sin3 Deacetylase Complex

Smith, K. T., Sardiu, M. E., Martin‐Brown, S., Seidel, C. W., Mushegian, A. R., Egidy, R., Florens, L. A., Washburn, M. P., & Workman, J. L. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.020255 · Cited by 55 · see citing works

Drug Development for Metastasis Prevention

Fontebasso, Y., & Dubinett, S. M. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v20.i5-6.150 · Cited by 57 · see citing works

Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage

Wang, H., Chen, M., Sang, X., You, X., Wang, Y., Paterson, I. C., Hong, W., & Yang, X. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112154 · Cited by 56 · see citing works

Elevated Expression of the Oncogene c-fms and Its Ligand, the Macrophage Colony-Stimulating Factor-1, in Cervical Cancer and the Role of Transforming Growth Factor-β1 in Inducing c-fms Expression

Kirma, N. B., Hammes, L. S., Liu, Y., Nair, H. B. B., Valente, P. T., Kumar, S. N., Flowers, L., & TEKMAL, R. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1991 · Cited by 56 · see citing works

Lesion environments direct transplanted neural progenitors towards a wound repair astroglial phenotype in mice

O’Shea, T. M., Ao, Y., Wang, S., Wollenberg, A. L., Kim, J. H., Espinoza, R. A. R., Czechanski, A., Reinholdt, L. G., Deming, T. J., & Sofroniew, M. V. (2022) · Nature Communications · doi:10.1038/s41467-022-33382-x · Cited by 54 · see citing works

Paraquat Induces Epithelial-Mesenchymal Transition-Like Cellular Response Resulting in Fibrogenesis and the Prevention of Apoptosis in Human Pulmonary Epithelial Cells

Yamada, A., Aki, T., Unuma, K., Funakoshi, T., & Uemura, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120192 · Cited by 50 · see citing works

Targeting Nodal in malignant melanoma cells

Postovit, L.-M. M., Seftor, E. A., Seftor, R. E. B., & Hendrix, M. J. C. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.4.497 · Cited by 49 · see citing works

Overcoming treatment resistance in cancer: Current understanding and tactics

Wu, G. J., Wilson, G., George, J., Liddle, C., Hebbard, L., & Qiao, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.018 · Cited by 49 · see citing works

Biphasic Role of Tgf-β Signaling during Müller Glia Reprogramming and Retinal Regeneration in Zebrafish

Sharma, P., Gupta, S., Chaudhary, M., Mitra, S., Chawla, B., Khursheed, M. A., Saran, N. K., & Ramachandran, R. (2020) · iScience · doi:10.1016/j.isci.2019.100817 · Cited by 48 · see citing works

Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma

Papoutsoglou, P., Louis, C., & Coulouarn, C. (2019) · Cells · doi:10.3390/cells8090960 · Cited by 48 · see citing works

Growth Differentiation Factor 11 Promotes Abnormal Proliferation and Angiogenesis of Pulmonary Artery Endothelial Cells

Yu, X., Chen, X., Zheng, X., Zhang, J., Zhao, X., Liu, Y., Zhang, H., Zhang, L., Yu, H., Zhang, M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10350 · Cited by 47 · see citing works

The CD 47‐binding peptide of thrombospondin‐1 induces defenestration of liver sinusoidal endothelial cells

Venkatraman, L., & Tucker‐Kellogg, L. (2013) · Liver International · doi:10.1111/liv.12231 · Cited by 46 · see citing works

Dynamics of TGF-β induced epithelial-to-mesenchymal transition monitored by Electric Cell-Substrate Impedance Sensing

Schneider, D., Tarantola, M., & Janshoff, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.07.016 · Cited by 46 · see citing works

Inhibition of TGFβ signaling and its implications in anticancer treatments.

Calone, I., & Souchelnytskyi, S. (2012) · PubMed · Cited by 46 · see citing works

A Specific Inhibitor of TGF-B Receptor Kinase, SB-431542, as a Potent Antitumor Agent for Human Cancers1

Halder, S. K., Beauchamp, R. D., & Datta, P. K. (2015)

Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo

Ge, R., Rajeev, V., Ray, P., Lattime, E. C., Rittling, S. R., Medicherla, S., Protter, A., Murphy, A., Chakravarty, J., Dugar, S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0162 · Cited by 154 · see citing works

Transforming Growth Factor-β (TGF-β) Signaling Inhibitors in Cancer Therapy

Datta, P. K., & Mann, J. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-293-9_35 · Cited by 3 · see citing works

Transforming growth factor β signaling pathway: A promising therapeutic target for cancer

Chen, Y., Di, C., Zhang, X., Wang, J., Wang, F., Yan, J., Xu, C., Zhang, J., Zhang, Q., Li, H., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29108 · Cited by 87 · see citing works

TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity

Ali, S., Rehman, M. U., Yatoo, A. M., Arafah, A. M., Khan, A., Rashid, S., Majid, S., Ali, A., & Ali, M. N. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175678 · Cited by 57 · see citing works